AI in Drug Development

Biotech and pharmaceutical companies are increasingly turning to AI to enhance drug development efficiency, with 38% already adopting the technology. A Tel Aviv startup, Quant Health, has raised $15 million to develop an AI platform that predicts clinical trial outcomes with 86% accuracy, aiming to address the declining success rates in clinical trials and optimize patient response predictions.